dementia
Atomic structure of tau revealed opening up new Alzheimer’s targets
July 6, 2017Research and Development Alzheimer's disease, dementia, tau protein, tau tangle
It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …
Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s
May 16, 2017Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia
The health care system in Cuba is widely held up to be a model of innovation; despite severe economic sanctions …
Behavioural intervention reduces need for antipsychotics in dementia treatment
April 19, 2017Research and Development antipsychotic, dementia
A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …
MSD joins charity-industry partnership Dementia Consortium
March 9, 2016Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium
The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
Heptares announces positive early-stage dementia trial results
February 10, 2016Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia
Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …
Lilly and Roche team up on new Alzheimer’s diagnostic test
January 28, 2016Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly
Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …
Alzheimer’s drugs prescriptions rise six-fold in a decade
January 19, 2016Manufacturing and Production Alzheimer's, Alzheimer's disease, NHSIC, dementia, prescribing
The number of prescriptions dispensed in England for approved medicines to treat Alzheimer’s increased from 502,000 in 2004 to 3 …
Chief scientific officers appointed at dementia Drug Discovery Alliance
December 3, 2015Medical Communications, Research and Development Alzheimer's Research, dementia, dementia drug discovery alliance
Alzheimer’s Research UK has appointed three chief scientific officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites …
UK government spends £300 million on dementia
February 23, 2015Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research
UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …
£30m drug discovery centres launched to overcome pharma ‘funding fatigue’
February 18, 2015Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma
Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …
UK government and partners pay £230m for disease research
October 23, 2014Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research
A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …
Mayor of London calls for dementia R&D centre
October 8, 2014Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research
The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …
Dementia diagnoses on the rise
July 30, 2014Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia
The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …
Mixed bag for Genentech dementia drug
July 18, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia
A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …
Alzheimer’s test ‘87% accurate’, say reports
July 9, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Alzheimer’s & dementia, Cameron, NHS, NHS Choices, dementia
NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …
Latest content
FibroFind appoints Lee Borthwick as CEO
